1. Home
  2. CPIX vs MDAI Comparison

CPIX vs MDAI Comparison

Compare CPIX & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • MDAI
  • Stock Information
  • Founded
  • CPIX 1999
  • MDAI 2013
  • Country
  • CPIX United States
  • MDAI United States
  • Employees
  • CPIX N/A
  • MDAI N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • MDAI Medical/Dental Instruments
  • Sector
  • CPIX Health Care
  • MDAI Health Care
  • Exchange
  • CPIX Nasdaq
  • MDAI Nasdaq
  • Market Cap
  • CPIX 51.5M
  • MDAI 51.9M
  • IPO Year
  • CPIX 2009
  • MDAI N/A
  • Fundamental
  • Price
  • CPIX $3.30
  • MDAI $2.20
  • Analyst Decision
  • CPIX
  • MDAI Strong Buy
  • Analyst Count
  • CPIX 0
  • MDAI 1
  • Target Price
  • CPIX N/A
  • MDAI $3.50
  • AVG Volume (30 Days)
  • CPIX 31.2K
  • MDAI 874.1K
  • Earning Date
  • CPIX 11-04-2025
  • MDAI 11-11-2025
  • Dividend Yield
  • CPIX N/A
  • MDAI N/A
  • EPS Growth
  • CPIX N/A
  • MDAI N/A
  • EPS
  • CPIX N/A
  • MDAI N/A
  • Revenue
  • CPIX $42,071,813.00
  • MDAI $27,549,000.00
  • Revenue This Year
  • CPIX N/A
  • MDAI N/A
  • Revenue Next Year
  • CPIX N/A
  • MDAI $60.05
  • P/E Ratio
  • CPIX N/A
  • MDAI N/A
  • Revenue Growth
  • CPIX 11.34
  • MDAI 22.27
  • 52 Week Low
  • CPIX $1.04
  • MDAI $1.01
  • 52 Week High
  • CPIX $7.25
  • MDAI $3.25
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 47.07
  • MDAI 46.67
  • Support Level
  • CPIX $3.41
  • MDAI $2.10
  • Resistance Level
  • CPIX $3.54
  • MDAI $2.69
  • Average True Range (ATR)
  • CPIX 0.19
  • MDAI 0.21
  • MACD
  • CPIX -0.02
  • MDAI -0.04
  • Stochastic Oscillator
  • CPIX 23.60
  • MDAI 14.29

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: